Danaher Corporation

NYSE:DHR

Medical - Diagnostics & Research

Healthcare
$228.41 -0.21%

-$0.38 today

Market cap
$160.69B
Beta
0.83
P/E (TTM)
34.0
EPS (TTM)
$5.21
Dividend yield
0.77%
52W Low $160.93High $242.80

Volume 2.92M

Average 4.52M

DHR Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

Danaher CorporationNYSE: DHR

Cash & Equivalents · Q3 FY2026 · quarter ended Sep 2026

Cash & equivalents rises 271.9% from a year ago

Cash & equivalents stood at $5.68B at the end of Q3 FY2026, up 271.9% from a year earlier and up 30.7% from the prior quarter. Over 3 fiscal years it compounded at -8.4% a year.

Context

  • Cash & equivalents amounted to 6.1% of total assets at the end of Q3 FY2026, up 4.2 pp from a year earlier.
  • Cash & equivalents increased in 1 of the last 3 fiscal years.

What to watch

Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +271.9% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2026
$5.68B+30.7% QoQ
Last fiscal yearDec 2025
$4.62B+122.1% YoY
Year agoSep 2025
$1.53B+271.9% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+271.9%——
1 year+122.1%——
3-year CAGR-8.4%——
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
4.62B USD
Year-over-year change
+122.1%
4-year CAGR
+15.6%

Cash & Equivalents vs competitors

How DHR compares with its peers on the latest reported figures

  • DHR's Sep 2026 cash & equivalents of $5.68B is the highest of the 9 companies compared; the peer median is $895.72M.
  • Its year-over-year change of +271.9% is the highest of 9, against a peer median of +12.9%.
  • Cash & equivalents amounts to 6.1% of total assets for DHR, versus a peer median of 6.6%.
DHR Competitors Peer median
Cash & Equivalents for DHR and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
DHRDanaher CorporationSep 2026$5.68B +271.9%-8.4%6.1%
TMOThermo Fisher Scientific Inc.Sep 2026$5.46B +175.5%+4.9%4.8%
AAgilent Technologies, Inc.Jul 2026$1.76B +14.5%+19.3%12.6%
ILMNIllumina, Inc.Jun 2026$1.04B +11.3%-11.0%15.6%
RVTYRevvity, Inc.Jul 2026$1.02B +3.1%+26.5%8.5%
QGENQiagen N.V.Jun 2026$768.5M +4.7%+4.7%13.0%
WATWaters CorporationJul 2026$539M +46.8%+6.9%2.2%
BRKRBruker CorporationJun 2026$184.9M +101.0%-22.6%3.1%
MTDMettler-Toledo International Inc.Jun 2026$51.38M -16.9%-11.3%1.4%
Peer median (excluding DHR) $895.72M+12.9%+4.8%6.6%

Competitors are the stored peer set for DHR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents2.59B6B5.86B2.08B4.62B
Short-term Investments00000
Net Receivables5.44B5.06B4.64B4.39B3.91B
Inventory2.77B2.77B2.59B2.33B2.49B
Other Current Assets82M1.36B71M79M1.74B
Total Current Assets11.65B15.88B13.94B9.5B12.76B
Property, Plant & Equipment (Net)4.83B4.59B5.61B6.07B6.75B
Goodwill41.18B37.28B41.61B40.5B43.15B
Intangible Assets22.84B19.82B20.75B18.57B17.82B
Long-term Investments1.32B2.16B1.7B1.82B1.55B
Tax Assets00000
Other Non-current Assets1.36B4.61B896M1.09B1.45B
Total Non-current Assets71.54B68.47B70.55B68.05B70.71B
Total Assets83.18B84.35B84.49B77.54B83.46B
Account Payables2.57B1.86B1.77B1.75B1.84B
Short-term Debt215M758M1.88B505M2M
Tax Payables707M691M582M00
Deferred Revenue1.61B1.46B1.47B1.3B0
Other Current Liabilities1.59B2.48B1.4B1.34B4.96B
Total Current Liabilities8.14B8.39B8.27B6.8B6.81B
Long-term Debt22.17B19.09B16.71B15.5B18.42B
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)213M221M249M232M0
Other Non-current Liabilities6.6B5.79B4.81B4.49B5.71B
Total Non-current Liabilities29.87B25.87B22.72B21.19B24.12B
Total Liabilities38.01B34.26B31B27.99B30.93B
Common Stock9M9M9M9M9M
Retained Earnings32.83B39.21B41.07B44.19B46.89B
Accumulated OCI(1.03B)(2.87B)(1.75B)(3.22B)(207M)
Other Stockholders Equity00000
Minority Interest10M8M4M7M7M
Total Equity45.18B50.09B53.49B49.55B52.54B
Total Debt23.27B20.62B19.54B17.15B18.42B
Net Debt20.69B14.62B13.67B15.07B13.8B

Danaher Corporation

NYSE:DHR

Intrinsic Alpha fair value

Locked

Current Price

$228.41

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.